Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Ryan L. Hanson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1159-3169; OpenAlex author ID A5060002469. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-21-0368↗
  2. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Co-author DOI 10.18632/oncotarget.9557↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Anthony Hollingsworth · 2 shared papers, 2016–2021 · strength 0.17
  2. Paul M. Grandgenett · 2 shared papers, 2016–2021 · strength 0.17
  3. Kamiya Mehla · 1 shared paper, 2021 · strength 0.10
  4. Thomas C. Caffrey · 1 shared paper, 2021 · strength 0.10
  5. Spas Dimitrov Markov · 1 shared paper, 2021 · strength 0.10
  6. Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.10
  7. Elizabeth M. Jaffee · 1 shared paper, 2021 · strength 0.10
  8. Surendra Kumar Shukla · 1 shared paper, 2021 · strength 0.10
  9. Prakash Radhakrishnan · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.